Results
10462
Most Popular Stocks on the market
10,462 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AAPL | US$218.80 | 0.1% | 13.6% | US$3.4t | US$226.18 | PE33.4x | E6.8% | 0.5% | Tech | ||
MSFT | US$422.92 | -1.4% | 29.1% | US$3.1t | US$497.68 | PE35.7x | E12.6% | 0.7% | Software | ||
NVDA | US$103.73 | -15.4% | 123.0% | US$2.7t | US$139.32 | PE59.8x | E23.3% | 0.04% | Semiconductors | ||
GOOGL | US$170.29 | -6.3% | 29.4% | US$2.1t | US$204.04 | PE23.9x | E12.2% | 0.5% | Media | ||
AMZN | US$181.71 | 0.5% | 41.7% | US$1.9t | US$222.55 | PE50.2x | E21.3% | n/a | Retail | ||
META | US$463.19 | -5.2% | 43.5% | US$1.2t | US$532.71 | PE25.7x | E12.2% | 0.4% | Media | ||
BRK.A | US$662,124.70 | 1.9% | 24.0% | US$951.1b | US$679,205.00 | PE13x | E-15.4% | n/a | Diversified Financials | ||
LLY | US$790.21 | -10.0% | 74.4% | US$727.3b | US$917.94 | PE115.9x | E27.4% | 0.7% | Pharmaceuticals & Biotech | ||
TSLA | US$222.62 | 3.1% | -12.4% | US$711.2b | US$204.16 | PE57.4x | E17.1% | n/a | Automobiles | ||
AVGO | US$143.52 | -12.4% | 56.0% | US$699.3b | US$192.97 | PE65.4x | E28.3% | 1.5% | Semiconductors | ||
JPM | US$215.19 | 3.2% | 38.5% | US$612.2b | US$221.90 | PB1.9x | E-2.9% | 2.1% | Banks | ||
WMT | US$69.19 | -2.1% | 30.5% | US$560.0b | US$73.40 | PE29.4x | E7.1% | 1.2% | Consumer Retailing | ||
UNH | US$576.33 | 3.9% | 14.2% | US$521.6b | US$615.13 | PE37.6x | E23.4% | 1.5% | Healthcare | ||
V | US$263.10 | -0.6% | 9.7% | US$497.7b | US$302.49 | PE26.6x | E9.6% | 0.8% | Diversified Financials | ||
XOM | US$118.17 | 4.2% | 10.8% | US$457.7b | US$132.96 | PE14.2x | E5.9% | 3.2% | Energy | ||
MA | US$447.45 | 3.5% | 14.7% | US$416.0b | US$514.15 | PE35.1x | E11.6% | 0.6% | Diversified Financials | ||
PG | US$161.70 | -3.0% | 3.5% | US$401.1b | US$174.56 | PE25.7x | E6.4% | 2.5% | Household | ||
JNJ | US$161.33 | 3.2% | -5.0% | US$388.4b | US$170.67 | PE23.7x | E7.1% | 3.1% | Pharmaceuticals & Biotech | ||
ORCL | US$135.67 | -2.2% | 17.3% | US$373.9b | US$148.92 | PE35.7x | E15.9% | 1.2% | Software | ||
COST | US$810.03 | -2.5% | 46.7% | US$359.1b | US$881.99 | PE50.1x | E7.4% | 0.6% | Consumer Retailing | ||
HD | US$363.69 | 1.1% | 9.5% | US$358.6b | US$383.14 | PE24.3x | E5.4% | 2.5% | Retail | ||
ABBV | US$186.78 | 7.9% | 25.7% | US$321.3b | US$193.12 | PE62.3x | E25.9% | 3.3% | Pharmaceuticals & Biotech | ||
BAC | US$41.28 | -2.2% | 32.4% | US$320.3b | US$45.48 | PB1.2x | E8.5% | 2.3% | Banks | ||
MRK | US$115.25 | -8.5% | 9.0% | US$291.9b | US$140.94 | PE21.3x | E14.4% | 2.7% | Pharmaceuticals & Biotech |